The impact of COVID-19 on opioid treatment program (OTP) services: Where do we go from here?

Kathlene Tracy, Leah Wachtel, Teri Friedman

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations


Medication for opioid use disorder (MOUD) services is key to addressing the opioid crisis and COVID-19 has significantly impacted MOUD delivery. The need for social distancing and self-quarantining requires individuals to maintain personal physical space and limits face-to-face interactions, which are required for methadone dispensing and other regulated treatment activities. Mount Sinai Beth Israel, which has one of the largest opioid treatment service (OTP) delivery systems within the United States and included 10 OTP methadone clinics that responded rapidly by implementing procedures to address the additional challenges during the COVID-19 pandemic. This article discusses four key procedural areas: 1) verified identity in-person pick-up doses, 2) drug urine toxicology screens, 3) treatment interactions, and 4) discharges, which can inform future OTP operational procedures by encouraging out-of-the-box thinking in this new age.

Original languageEnglish
Article number108394
JournalJournal of Substance Abuse Treatment
StatePublished - Dec 2021


  • Addiction services
  • COVID-19
  • Medication for opioid use disorders
  • Methadone
  • Opioid use disorder


Dive into the research topics of 'The impact of COVID-19 on opioid treatment program (OTP) services: Where do we go from here?'. Together they form a unique fingerprint.

Cite this